SANGANI HOSPITALS Stock Price Today (NSE: SANGANI)
Fundamental Score
SANGANI HOSPITALS Share Price — Live NSE/BSE Price, Fundamentals & Analysis
SANGANI HOSPITALS share price today is ₹39.00, down 2.50% on NSE/BSE as of 16 April 2026. SANGANI HOSPITALS (SANGANI) is a Small-cap company in the Hospital sector with a market capitalisation of ₹85.42 (Cr). The 52-week high for SANGANI share price is ₹77.00 and the 52-week low is ₹39.00. At a P/E ratio of 45.20x, SANGANI is currently trading below its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 7.44% and a debt-to-equity ratio of 0.03.
SANGANI HOSPITALS Share Price Chart — NSE/BSE Historical Performance
AI Research Briefing
Powered by Gemini · 2026-04-08
Micro-cap hospital play trading on hope, not current performance; avoid until earnings justify the valuation.
⚡ WHAT'S HAPPENING NOW (last 2-4 weeks): No major catalysts found after live search. The latest news indicates a mixed sentiment with some positive news regarding other hospitals and the Indian Rupee, but also negative news concerning the Rupee's performance and potential cost increases in healthcare due to the Iran War. 🧠 CORE STORY (THE REAL GAME): Sangani Hospitals is a micro-cap play in the Indian healthcare sector. The core story revolves around its potential to capitalize on the growing demand for healthcare services in India, but its small size introduces significant risk. 🔥 WHAT IS DRIVING THE STOCK: 1. **Sector Growth:** Overall growth in the Indian hospital sector is a tailwind. 2. **Micro-cap Speculation:** Micro-caps can experience rapid price swings based on speculation. ⚖️ BULL vs BEAR: Bull: Potential for high growth if Sangani can effectively scale operations and capture market share in a growing sector. Bear: Micro-cap with low liquidity, negative profit growth, and dependence on a single hospital or small chain. Any operational hiccup or adverse event can trigger a massive sell-off. High P/E of 45.2x with negative profit growth leaves no room for error. 💣 WHAT MARKET IS PRICING: Market is likely pricing in optimistic growth projections despite the company's recent negative profit growth and small size. This expectation is fragile. 🎯 BOTTOM LINE: Sangani Hospitals is a high-risk, high-reward micro-cap play where current valuation doesn't reflect recent negative profit growth, making it vulnerable to a correction.
- Overall sector growth
- Micro-cap speculation
- Recent positive news sentiment (5.7/10)
- Significant earnings beat
- Major contract win
- Acquisition by a larger player
- Micro/SME cap - liquidity risk
- Negative latest quarter YoY profit (-41.52%)
- High P/E (45.2x) with negative profit growth
- Low free cash flow
FII ownership decreased slightly (-0.02%), indicating a lack of strong institutional interest.
Geopolitical tensions (Iran War) could increase input costs for hospitals, creating a headwind.
No - Free cash flow is negligible (₹None Cr).
In the next 3-6 months, watch for earnings reports and any announcements regarding expansion or new contracts. A significant earnings beat is needed to justify the current valuation.
Primary Thesis Risk
Inability to translate revenue growth into sustained profitability will crush the stock.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
SANGANI HOSPITALS Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
SANGANI HOSPITALS Share Price: A Financial Analysis for Growth
The hospital sector, while recession-resistant due to essential healthcare needs, faces challenges in operational efficiency and profitability. This analysis examines the financial health of SANGANI HOSPITALS, with specific attention to its current valuation. Currently, the SANGANI HOSPITALS share price stands at ₹49.900002. We will delve into key ratios and compare them with sector peers to assess its competitive positioning.
A critical metric is the Price-to-Earnings (PE) ratio. SANGANI HOSPITALS' PE of 45.2 indicates that the market is pricing its earnings relatively high compared to its peers. While a high PE can reflect investor confidence and growth expectations, it also suggests a potential overvaluation if future earnings growth does not materialize. It would be helpful to compare how the company is managing corporate governance vs a peer like
Nephro Care India Limited. Is the higher PE justified by better management or a stronger track record of execution compared to other players?Return on Capital Employed (ROCE) is a crucial indicator of how efficiently a company utilizes its capital to generate profits. SANGANI HOSPITALS' ROCE of 9.91% reveals the returns generated by its investments. A lower ROCE compared to the cost of capital could signify challenges in creating a strong economic moat. With only 9.91% ROCE there's less potential to fund organic growth, expand facilities, or implement innovative technologies that would widen a competitive advantage and protect their market share.
Comparison with sector peers such as Strategic Minerals Plc and Abateas Industries Ltd. provides a broader context. Analyzing their respective PE ratios, ROCE, and management quality will help determine whether SANGANI HOSPITALS' current valuation is justified. This observational financial analysis is part of a larger 80-parameter fundamental audit, verified by Sweta Mishra, focusing on long-term growth potential and risk factors. Note this analysis is for informational purposes and does not constitute financial advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
SANGANI HOSPITALS Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SANGANI across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Strong Revenue Growth (104.50%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.03)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (73.22%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Below-Average Return on Equity (7.44%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (9.91%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 45.20x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-41.52%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
SANGANI HOSPITALS Financial Statements
Comprehensive financial data for SANGANI HOSPITALS including income statement, balance sheet and cash flow
About SANGANI (SANGANI HOSPITALS)
SANGANI HOSPITALS (SANGANI) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Hospital sector with a current mark...et capitalisation of ₹85.42 (Cr). SANGANI HOSPITALS has delivered a Return on Equity (ROE) of 7.44% and a ROCE of 9.91%. The debt-to-equity ratio stands at 0.03, reflecting the company's capital structure. Investors tracking SANGANI share price can monitor key metrics including P/E ratio, promoter holding of 73.22%, and quarterly earnings growth.
Company Details
SANGANI Share Price: Frequently Asked Questions
What is the current share price of SANGANI HOSPITALS (SANGANI)?
As of 16 Apr 2026, 11:00 am IST, SANGANI HOSPITALS share price is ₹39.00. The SANGANI stock has a market capitalisation of ₹85.42 (Cr) on NSE/BSE.
Is SANGANI share price Overvalued or Undervalued?
SANGANI share price is currently trading at a P/E ratio of 45.20x, compared to the industry average of 52.84x. Based on this relative valuation, the SANGANI HOSPITALS stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of SANGANI share price?
The 52-week high of SANGANI share price is ₹77.00 and the 52-week low is ₹39.00. These values are updated daily from NSE/BSE price data.
What factors affect the SANGANI HOSPITALS share price?
Key factors influencing SANGANI share price include quarterly earnings growth (Sales Growth: 104.50%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is SANGANI HOSPITALS a good stock for long-term investment?
SANGANI HOSPITALS shows a 5-year Profit Growth of N/A% and an ROE of 7.44%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.03 before investing in SANGANI shares.
How does SANGANI HOSPITALS compare with its industry peers?
SANGANI HOSPITALS competes with major peers in the Hospital. Investors should compare SANGANI share price P/E of 45.20x and ROE of 7.44% against the industry averages to determine competitive standing.
What is the P/E ratio of SANGANI and what does it mean?
SANGANI share price has a P/E ratio of 45.20x compared to the industry average of 52.84x. Investors pay ₹45 for every ₹1 of annual earnings.
How is SANGANI performing according to Bull Run's analysis?
SANGANI has a Bull Run fundamental score of 28.8/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does SANGANI belong to?
SANGANI operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting SANGANI HOSPITALS share price.
What is Return on Equity (ROE) and why is it important for SANGANI?
SANGANI has an ROE of 7.44%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently SANGANI HOSPITALS generates profits from shareholders capital.
How is SANGANI debt-to-equity ratio and what does it indicate?
SANGANI has a debt-to-equity ratio of 0.03, which indicates conservative financing with low financial risk.
What is SANGANI dividend yield and is it a good dividend stock?
SANGANI offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in SANGANI HOSPITALS shares.
How has SANGANI share price grown over the past 5 years?
SANGANI has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in SANGANI and why does it matter?
Promoters hold 73.22% of SANGANI shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in SANGANI HOSPITALS.
What is SANGANI market capitalisation category?
SANGANI has a market capitalisation of ₹85 crores, placing it in the Small-cap category.
How volatile is SANGANI stock?
SANGANI has a beta of N/A. A beta > 1 suggests the SANGANI HOSPITALS stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is SANGANI operating profit margin trend?
SANGANI has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is SANGANI quarterly performance?
Recent quarterly performance shows SANGANI HOSPITALS YoY Sales Growth of 104.50% and YoY Profit Growth of -41.52%.
What is the institutional holding pattern in SANGANI?
SANGANI has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the SANGANI HOSPITALS stock.